Statement on an organic certification review
In May 2025, the Servicio Agrícola y Ganadero (SAG) notified Desert King Chile S.A. of a complaint concerning three organic production batches from 2021. An internal review identified a [...]
Desert King Strengthens Its Role in Global Health at World Vaccine Congress 2026
Desert King participated in The World Vaccine Congress Washington 2026, one of the most relevant global events in the vaccine industry, reaffirming its commitment to developing sustainable and [...]
Bai, D., et al. Impact of Side Chain Structure and Aglycon Carbonyl Group on the Immunostimulatory Activities of Semisynthetic Saponin Adjuvants. ACS Pharmacol Transl Sci, 2026 Feb 20, 9(3):706-715, PMID: 41852640
The saponin QS-21, derived from Quillaja saponaria, has been clinically successful in vaccines due to its ability to elicit robust humoral and cellular immunity, exemplified by its inclusion in [...]
Luo, Z., et al. Developing a Next-Generation Vaccine Adjuvant System through Rational Design to Alleviate AS01 Adjuvant Deficiency. J Med Chem, 2026 Mar 19, PMID: 41855509
This research addresses the critical need to improve vaccine adjuvants, which are essential for enhancing immune responses in subunit vaccines. While AS01 has demonstrated potent [...]
Bundi, C.K., et al. B and T cell responses to pre-erythrocytic R21/Matrix-M and blood- stage RH5.1/Matrix-M malaria vaccines in endemic settings. Front Immunol, 2026 Mar 2, 17:1743327, PMID: 41846927
Malaria remains a major global health challenge, particularly in endemic regions where effective vaccines are critically needed. Recent advances include the development of vaccines targeting [...]
Devine, J., et al. Infection, vaccination and risk of dementia: a proposed immunological model. Front Immuno, 2026 Mar 4, 17:1748535, PMID: 41859113
This paper emphasizes the growing global burden of dementia, particularly Alzheimer's disease, which is predicted to nearly double by 2050 due to aging populations worldwide. It [...]
San Martín, R., et al. Structure and immunological activity of QS-21 variant from Quillaja saponaria aerial biomass. Front Immunol, 2026 Mar 9, 17:1771912, PMID: 41878432
This study focuses on QS-21, a potent saponin adjuvant essential for human vaccines, traditionally sourced from the bark of mature Quillaja saponaria trees in Chile. The researchers identified a [...]
Osbourn, A. The Cinderella tree, Quillaja saponaria – A soap story. Plants People Planet. 2026 Mar, 8(2):439-451, PMID: 41743997
The Quillaja saponaria tree, native to central Chile, has historically been valued for its soap-like bark containing saponins, which produce foam and have traditional cleaning uses. Its [...]
Desert King Supports Research on QS-21 Supply and Vaccine Scalability
A new article published in Frontiers in Immunology highlights the challenges and opportunities associated with scaling the production of QS-21, a key vaccine adjuvant derived [...]